Loading...
•
Sep 30, 2024
The Joint Q3 2024 Earnings Report
The Joint Corp. reported Q3 2024 financial results.
Key Takeaways
The Joint Corp. reported a 2% increase in revenue to $30.2 million, but net loss was $3.2 million, including $3.8 million in loss on disposition or impairment. System-wide sales increased 8% to $129.3 million.
Revenue grew 2% to $30.2 million.
Net loss was $3.2 million, including $3.8 million in loss on disposition or impairment.
Adjusted EBITDA was $2.4 million.
System-wide sales increased 8% to $129.3 million.
Forward Guidance
The company adjusted its guidance to account the potential impact of ongoing consumer headwinds.
Positive Outlook
- System-wide sales are expected to be between $525 million and $535 million.
- System-wide comp sales for all clinics open 13 months or more are expected to be between 3% and 4%.
- New franchised clinic openings, excluding the impact of refranchised clinics, are expected to be between 55 and 60.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...